S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
U.S. Loses to China in Shocking WAR GAMES (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
U.S. Loses to China in Shocking WAR GAMES (Ad)
How major US stock indexes fared Friday, 9/29/2023
MarketBeat Week in Review – 9/25 - 9/29
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
U.S. Loses to China in Shocking WAR GAMES (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
U.S. Loses to China in Shocking WAR GAMES (Ad)
How major US stock indexes fared Friday, 9/29/2023
MarketBeat Week in Review – 9/25 - 9/29
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
U.S. Loses to China in Shocking WAR GAMES (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
U.S. Loses to China in Shocking WAR GAMES (Ad)
How major US stock indexes fared Friday, 9/29/2023
MarketBeat Week in Review – 9/25 - 9/29
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
U.S. Loses to China in Shocking WAR GAMES (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
U.S. Loses to China in Shocking WAR GAMES (Ad)
How major US stock indexes fared Friday, 9/29/2023
MarketBeat Week in Review – 9/25 - 9/29
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
NASDAQ:RMTI

Rockwell Medical (RMTI) Stock Forecast, Price & News

$2.08
+0.08 (+4.00%)
(As of 09/29/2023 ET)
Compare
Today's Range
$2.03
$2.19
50-Day Range
$1.83
$3.61
52-Week Range
$0.84
$6.24
Volume
301,639 shs
Average Volume
298,715 shs
Market Capitalization
$59.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00

Rockwell Medical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
428.8% Upside
$11.00 Price Target
Short Interest
Healthy
3.56% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.35
Upright™ Environmental Score
News Sentiment
0.80mentions of Rockwell Medical in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.43) to ($0.05) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.35 out of 5 stars

Medical Sector

235th out of 970 stocks

Pharmaceutical Preparations Industry

91st out of 449 stocks


RMTI stock logo

About Rockwell Medical (NASDAQ:RMTI) Stock

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in patients undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including cleaning agents, 6% bleach for disinfection, citric acid descale, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

RMTI Price History

RMTI Stock News Headlines

HC Wainwright Reaffirms Buy Rating for Rockwell Medical (NASDAQ:RMTI)
Elon Musk May Have Just Changed Everything
Quantum computing, 3D Printing and Gene-Editing are 3 most disruptive pieces of technology in recent times. None compare to a project Elon Musk released which could mint the world’s first trillionaire. 
Elon Musk May Have Just Changed Everything
Quantum computing, 3D Printing and Gene-Editing are 3 most disruptive pieces of technology in recent times. None compare to a project Elon Musk released which could mint the world’s first trillionaire. 
H.C. Wainwright Sticks to Their Buy Rating for Rockwell Med (RMTI)
Q2 2023 Rockwell Medical Inc Earnings Call
Why Rockwell Medical Shares Are Surging Today
Rockwell Medical Announces Second Quarter 2023 Results
See More Headlines
Receive RMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter.

RMTI Company Calendar

Last Earnings
8/14/2023
Today
9/30/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:RMTI
CUSIP
77437410
Employees
253
Year Founded
1995

Price Target and Rating

Average Stock Price Forecast
$11.00
High Stock Price Forecast
$11.00
Low Stock Price Forecast
$11.00
Forecasted Upside/Downside
+428.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-18,680,000.00
Pretax Margin
-15.32%

Debt

Sales & Book Value

Annual Sales
$72.81 million
Book Value
$1.16 per share

Miscellaneous

Free Float
27,863,000
Market Cap
$59.26 million
Optionable
Optionable
Beta
1.40

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Dr. Mark Strobeck Ph.D. (Age 52)
    Pres, CEO & Director
    Comp: $643.41k
  • Ms. Megan C. Timmins (Age 50)
    Exec. VP, Chief Legal Officer & Sec.
    Comp: $518.09k
  • Mr. Paul E. McGarry (Age 55)
    SVP of Fin. & Chief Accounting Officer
  • Mr. James A. McCarthy
    Sr. VP of Bus. & Corp. Devel.
  • Mr. Timothy T. Chole
    Sr. VP of Sales & Marketing
  • Ms. Heather R. Hunter
    Sr. VP & Chief Corp. Affairs Officer
  • Mr. David J. Kull (Age 55)
    Sec.
  • Mr. Jason Finkelstein
    Investor Relations Representative













RMTI Stock - Frequently Asked Questions

Should I buy or sell Rockwell Medical stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RMTI shares.
View RMTI analyst ratings
or view top-rated stocks.

What is Rockwell Medical's stock price forecast for 2023?

1 Wall Street research analysts have issued twelve-month target prices for Rockwell Medical's shares. Their RMTI share price forecasts range from $11.00 to $11.00. On average, they expect the company's stock price to reach $11.00 in the next year. This suggests a possible upside of 428.8% from the stock's current price.
View analysts price targets for RMTI
or view top-rated stocks among Wall Street analysts.

How have RMTI shares performed in 2023?

Rockwell Medical's stock was trading at $1.0150 on January 1st, 2023. Since then, RMTI shares have increased by 104.9% and is now trading at $2.08.
View the best growth stocks for 2023 here
.

Are investors shorting Rockwell Medical?

Rockwell Medical saw a drop in short interest in September. As of September 15th, there was short interest totaling 888,800 shares, a drop of 20.6% from the August 31st total of 1,120,000 shares. Based on an average daily volume of 1,100,000 shares, the days-to-cover ratio is currently 0.8 days. Currently, 3.6% of the shares of the stock are short sold.
View Rockwell Medical's Short Interest
.

When is Rockwell Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our RMTI earnings forecast
.

How were Rockwell Medical's earnings last quarter?

Rockwell Medical, Inc. (NASDAQ:RMTI) announced its quarterly earnings data on Monday, August, 14th. The company reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.12) by $0.06. The company had revenue of $18.08 million for the quarter, compared to analysts' expectations of $18.08 million. Rockwell Medical had a negative trailing twelve-month return on equity of 88.74% and a negative net margin of 15.32%. During the same period last year, the firm posted ($0.56) earnings per share.

When did Rockwell Medical's stock split?

Rockwell Medical's stock reverse split on Friday, May 13th 2022. The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.

What guidance has Rockwell Medical issued on next quarter's earnings?

Rockwell Medical issued an update on its FY 2023 earnings guidance on Sunday, September, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $82.00 million-$86.00 million, compared to the consensus revenue estimate of $86.08 million.

What is Robert L. Chioini's approval rating as Rockwell Medical's CEO?

6 employees have rated Rockwell Medical Chief Executive Officer Robert L. Chioini on Glassdoor.com. Robert L. Chioini has an approval rating of 22% among the company's employees. This puts Robert L. Chioini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Rockwell Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seagen (SGEN), Geron (GERN), OPKO Health (OPK), Amarin (AMRN), Gilead Sciences (GILD), ImmunoGen (IMGN), Sorrento Therapeutics (SRNE) and VBI Vaccines (VBIV).

What is Rockwell Medical's stock symbol?

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

How do I buy shares of Rockwell Medical?

Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Rockwell Medical's stock price today?

One share of RMTI stock can currently be purchased for approximately $2.08.

How much money does Rockwell Medical make?

Rockwell Medical (NASDAQ:RMTI) has a market capitalization of $59.26 million and generates $72.81 million in revenue each year. The company earns $-18,680,000.00 in net income (profit) each year or ($0.88) on an earnings per share basis.

How many employees does Rockwell Medical have?

The company employs 253 workers across the globe.

How can I contact Rockwell Medical?

Rockwell Medical's mailing address is 411 HACKENSACK AVENUE SUITE 501, HACKENSACK NJ, 07601. The official website for the company is www.rockwellmed.com. The company can be reached via phone at (248) 432-1362, via email at invest@rockwellmed.com, or via fax at 248-960-9119.

This page (NASDAQ:RMTI) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -